Back to discover
Disease
Eclampsia
Late-stage therapeutic developmentEmerging research
1
Publications
18
Clinical trials
2022
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2022-11-15BMC medicine
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 3 clinical trials expected to report results, the earliest in Q3 2026.
Major developments
Upcoming trial readoutHigh impact
Results expected Q3 20262026-06-04
Upcoming trial readoutHigh impact
Results expected Q3 20282026-05-07
Clinical MilestonesViewHide
Results expected
- 2026-06-04Treatment With Aspirin After Preeclampsia: TAP TrialResults expected Q3 2026
- 2026-05-07Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes in Nulliparous Women After Assisted Reproductive Technology. APPARTResults expected Q3 2028
- 2026-01-20APPLE: Aspirin to Prevent Pregnancy Loss and PreeclampsiaResults expected Q2 2029
Recently completed
- 2026-02-08Role of Vitamin D in Prevention of Preeclampsia Recurrence in Pregnant Women With Previous History of Preeclampsia: A Randomized Controlled TrialPrimary completion
- 2025-11-12Frequency of Recurrence of Seizures With Intravenous Versus Intramuscular Magnesium Sulphate in Women With EclampsiaCompleted
Activity timeline5
- 2026-06-04ClinicalTreatment With Aspirin After Preeclampsia: TAP TrialResults expected Q3 2026
- 2026-05-07ClinicalAspirin for the Prevention of Preeclampsia and Pregnancy Outcomes in Nulliparous Women After Assisted Reproductive Technology. APPARTResults expected Q3 2028
- 2026-02-08ClinicalRole of Vitamin D in Prevention of Preeclampsia Recurrence in Pregnant Women With Previous History of Preeclampsia: A Randomized Controlled TrialPrimary completion
- 2026-01-20ClinicalAPPLE: Aspirin to Prevent Pregnancy Loss and PreeclampsiaResults expected Q2 2029
- 2025-11-12ClinicalFrequency of Recurrence of Seizures With Intravenous Versus Intramuscular Magnesium Sulphate in Women With EclampsiaCompleted
Clinical trials
The current development programme across all trial phases.
Clinical programme
18
6
15
6
Late-stage studies
Recruiting
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Most influential
Major themes3
- Eclampsia1
- Gastrointestinal Microbiome1
- Pre-Eclampsia1
Leading journals1
- BMC medicine1
Leading researchers8
- Chen G1
- Fan D1
- Gou X1
- Guo L1
- Guo X1
- Li P1
- Lin D1
- Liu Z1
Affiliations (unnormalised)3
- Affiliated Foshan Maternity & Child Healthcare Hospital1
- Foshan Fetal Medicine Research Institute1
- School of Public Health1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Onset of HYPERREFLEXIA; SEIZURES; or COMA in a previously diagnosed pre-eclamptic patient (PRE-ECLAMPSIA).
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.